Physician

Stacey K Knox, MD

According to 2025 Medicare claims, Stacey Knox, MD (NPI: 1750353447) practices hematology/oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CANCER PARTNERS OF NEBRASKA PC (NPI: 1437111408; TIN: 911862785) and primary practice location at 68516-5587. Knox is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Knox's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 995 traditional Medicare patients, billed 185,478 HCPCS/CPT codes, and received $2,917,365 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,244 prescription claims across 180 beneficiaries totaling $3,853,222 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 44 claims. Open Payments data shows 21 records totaling $35,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $662,963 to $3,853,222. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	873	153,804	$2,092,610
2016	913	151,856	$2,575,765
2017	1,016	170,292	$2,320,789
2018	941	200,174	$2,463,113
2019	1,127	200,125	$2,740,801
2020	1,042	189,023	$2,996,400
2021	1,094	202,606	$2,869,087
2022	1,054	199,276	$2,659,421
2023	1,148	195,074	$2,781,720
2024	995	185,478	$2,917,365

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	169	1,134	$662,963
2016	174	1,082	$583,726
2017	167	1,003	$608,236
2018	149	843	$628,075
2019	161	1,057	$1,092,155
2020	161	957	$1,563,494
2021	146	916	$799,516
2022	159	1,091	$1,169,005
2023	170	1,105	$2,654,290
2024	180	1,244	$3,853,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	146	$36,722
2016	N/R	140	$30,759
2017	N/R	11	$176
2018	N/R	11	$552
2019	N/R	96	$7,910
2020	12	22	$1,021
2021	N/R	16	$803
2022	N/R	11	$739
2023	N/R	17	$1,014
2024	13	44	$1,576

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	388	902	$84
80053	Blood test, comprehensive group of blood chemicals	522	943	$10
36415	Insertion of needle into vein for collection of blood sample	532	1,047	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	606	1,326	$8
83615	Lactate dehydrogenase (enzyme) level	390	667	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	66	1,848	$897,969
Revlimid	Lenalidomide	38	1,064	$699,143
Ibrance	Palbociclib	29	812	$473,275
Imbruvica	Ibrutinib	29	812	$452,043
Kisqali	Ribociclib Succinate	16	448	$267,867

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	13	22	$1,219
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	11	$207
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$192	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	12	$35,475	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stacey K. Knox, MD?

Tedicare shows public-source Medicare data for Stacey K. Knox, MD (NPI 1750353447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stacey K. Knox, MD have ACO affiliation data?

Stacey K. Knox, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Stacey K. Knox, MD?

Stacey K. Knox, MD is linked to CANCER PARTNERS OF NEBRASKA PC (billing NPI 1437111408) in the available physician profile data.

Does Stacey K. Knox, MD have Open Payments data?

Stacey K. Knox, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.